Can tailored nutrition boost recovery from head and neck surgery?
NCT ID NCT07759193
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This study looks at how many calories patients with head and neck cancer need before and after free flap reconstructive surgery. Researchers will use indirect calorimetry to measure energy use at several time points, along with body composition and diet questionnaires. The goal is to better understand nutritional needs during recovery, which could improve care for future patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Indirect calorimetry (a diagnostic test measuring energy expenditure)
- What this could lead to
- If successful, this could improve nutritional care and recovery for future head and neck cancer patients undergoing major surgery.
- What could go wrong
- This is a small observational study, so results may not apply broadly. It does not test a treatment, so it won't directly change care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FREE TISSUE FLAPS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ichilov Hospital
RECRUITINGTel Aviv, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could fear of movement slow spine surgery recovery?
- Can less radiation be safer for throat cancer?
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Can a new drug boost the power of chemoradiation against head and neck cancer?
- Can a simple frailty check predict how well seniors recover from heart surgery?
- Exercise after cancer therapy: a new way to gauge prognosis?